Precision Antisense Oligonucleotide Therapy Amenability for Infantile Genetic Epilepsies.
Sherrill E +26 more
europepmc +1 more source
N-of-1 investigational study of a novel antisense oligonucleotide drug in CHCHD10-related ALS shows early signs of efficacy. [PDF]
Cousin MA +17 more
europepmc +1 more source
Retraction: MiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7.
PLOS ONE Editors
doaj +1 more source
Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression. [PDF]
Trew I, Wilton SD, Cale JM, Aung-Htut M.
europepmc +1 more source
Inhaled Angiopoietin-Like 4 Antisense Oligonucleotide Therapy for Lung Injury and Fibrosis. [PDF]
Fan H +21 more
europepmc +1 more source
Neural Stem Cell-Derived Extracellular Vesicles Improve CNS Delivery and Therapeutic Efficacy of Antisense Oligonucleotide in Amyotrophic Lateral Sclerosis. [PDF]
Zheng Y +8 more
europepmc +1 more source
Bottlebrush polymer conjugates for enhanced antisense oligonucleotide therapy in myotonic dystrophy type 1. [PDF]
Li Y +15 more
europepmc +1 more source
FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. [PDF]
Moriyama H, Moriyama S, Yokota T.
europepmc +1 more source
The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery. [PDF]
Ruchi R +5 more
europepmc +1 more source

